Jiangxi Sanxin Medtec Co.,Ltd. (300453.SZ)
CNY 7.99
(-0.37%)
CNY 7.99
(-0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 346.14 Million | 402.17 Million | 329.71 Million | 272.89 Million | 167.35 Million | 58.88 Million |
| Net Income | 206.63 Million | 199.09 Million | 171.81 Million | 128.98 Million | 66.53 Million | 40.9 Million |
| Depreciation & Amortization | 78.26 Million | 65.75 Million | 58.47 Million | 49.83 Million | 35.1 Million | 28.94 Million |
| Deferred income taxes | -593.53 Thousand | 3.78 Million | -1.22 Million | -1.92 Million | -1.15 Million | -396.48 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 43.17 Million | 100.52 Million | 79.54 Million | 83.08 Million | 48.29 Million | -15.44 Million |
| Other non-cash items | 140.35 Million | 36.79 Million | 19.88 Million | 10.98 Million | 17.42 Million | 4.47 Million |
| Investing Cash Flow | -425.76 Million | -375.64 Million | -63.7 Million | -235.03 Million | -173.13 Million | -152.87 Million |
| Investments in PPE | -287.47 Million | -210.55 Million | -174.8 Million | -98.13 Million | -123.04 Million | -132.43 Million |
| Acquisitions | 498.98 Thousand | 22.62 Thousand | 60.3 Thousand | 42.12 Thousand | -46.28 Million | 165.41 Thousand |
| Investment purchases | -507.06 Million | -365 Million | -343.54 Million | -937.3 Million | -345 Million | -414.75 Million |
| Sales/Maturities of investments | 367.44 Million | 199.06 Million | 453.76 Million | 799.13 Million | 339.61 Million | 394.7 Million |
| Other Investing Activities | 823.05 Thousand | 816.48 Thousand | 816.48 Thousand | 1.21 Million | 1.57 Million | -562.08 Thousand |
| Financing Cash Flow | -9.18 Million | 35.42 Million | -134.31 Million | -50.94 Million | 28.66 Million | 88.9 Million |
| Debt repayment | -75.23 Million | -304 Million | -177.33 Million | -171.37 Million | -107.29 Million | -17.6 Million |
| Dividends payments | -59.6 Million | -59.1 Million | -52.53 Million | -26.27 Million | -16.33 Million | -17.6 Million |
| Common Stock Repurchased | - | - | - | -78.8 Thousand | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 125.65 Million | 401.69 Million | 96.99 Million | 148.44 Million | 158.61 Million | 124.1 Million |
| Accounts receivables | -9.36 Million | 10.18 Million | -33.42 Million | 31.78 Million | -63.58 Million | 44.67 Million |
| Accounts payables | 48.94 Million | 127.14 Million | 125 Million | 58.38 Million | 137.2 Million | -40.58 Million |
| Inventory | -4.72 Million | -40.58 Million | -10.81 Million | -5.16 Million | -24.17 Million | -19.13 Million |
| Other working capital | 8.32 Million | 3.78 Million | -1.22 Million | -1.92 Million | -1.15 Million | 3.69 Million |
| Cash at beginning of period | 320.33 Million | 221.88 Million | 91.96 Million | 104.22 Million | 81.58 Million | 86.67 Million |
| Cash at end of period | 221.28 Million | 285.41 Million | 221.88 Million | 91.96 Million | 104.22 Million | 81.58 Million |
| Capital Expenditure | -287.47 Million | -210.55 Million | -174.8 Million | -98.13 Million | -123.04 Million | -132.43 Million |
| Effect of forex changes on cash | 759.24 Thousand | 1.57 Million | -1.77 Million | 821.34 Thousand | -247.84 Thousand | - |
| Net cash flow / Change in cash | -99.04 Million | 63.53 Million | 129.91 Million | -12.26 Million | 22.63 Million | -5.09 Million |
| Free Cash Flow | 58.67 Million | 191.62 Million | 154.91 Million | 174.76 Million | 44.3 Million | -73.54 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 61.66 Million | 52.62 Million | 53.61 Million | 65.22 Million | 206.63 Million | 51.93 Million |
| Depreciation & Amortization | - | 19.19 Million | 19.19 Million | 19.6 Million | 78.26 Million | 19.6 Million |
| Deferred income taxes | - | -1.99 Million | - | - | -593.53 Thousand | -2.2 Million |
| Stock-based compensation | - | 2.34 Million | - | - | - | -5.19 Million |
| Change in working capital | - | 1.85 Million | - | -5.77 Million | 43.17 Million | 7.4 Million |
| Other non-cash items | 125.85 Million | 69.66 Million | -16.47 Million | 54.32 Million | 140.35 Million | 40.99 Million |
| Investing Cash Flow | -129.08 Million | -92.84 Million | -4.8 Million | -129.77 Million | -425.76 Million | -110.04 Million |
| Investments in PPE | -46.17 Million | -52.84 Million | -57.5 Million | -109.43 Million | -287.47 Million | -61.35 Million |
| Acquisitions | - | - | 462 Thousand | 498.98 Thousand | 498.98 Thousand | 0.05 |
| Investment purchases | -133 Million | -60 Million | -30 Million | -261 Million | -507.06 Million | -100 Million |
| Sales/Maturities of investments | 50.09 Million | 20 Million | 82.24 Million | 239.94 Million | 367.44 Million | 51.1 Million |
| Other Investing Activities | - | -39.65 Million | 54.17 Million | 210.69 Thousand | 823.05 Thousand | 204.12 Thousand |
| Financing Cash Flow | -64.58 Million | -65.87 Million | -55.98 Million | 21.07 Million | -9.18 Million | -13.87 Million |
| Debt repayment | -24.63 Million | -18.63 Million | -22 Million | -75.23 Million | -75.23 Million | -25 Million |
| Dividends payments | -54.44 Million | -76.69 Million | -1.22 Million | -59.6 Million | -59.6 Million | -1.07 Million |
| Common Stock Repurchased | - | -43.45 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -34.76 Million | -7.81 Million | -77.98 Million | 155.92 Million | 125.65 Million | 12.19 Million |
| Accounts receivables | - | -3.1 Million | - | -9.36 Million | -9.36 Million | 2.53 Million |
| Accounts payables | - | - | - | - | 48.94 Million | - |
| Inventory | - | 286.83 Thousand | - | -4.72 Million | -4.72 Million | 18.12 Million |
| Other working capital | - | 4.66 Million | - | 8.32 Million | 8.32 Million | -13.25 Million |
| Cash at beginning of period | 117.68 Million | 182.83 Million | 221.28 Million | 198.64 Million | 320.33 Million | 184.19 Million |
| Cash at end of period | 111.43 Million | 126.26 Million | 182.83 Million | 221.28 Million | 221.28 Million | 172.12 Million |
| Capital Expenditure | -46.17 Million | -52.84 Million | -57.5 Million | -109.43 Million | -287.47 Million | -61.35 Million |
| Effect of forex changes on cash | -8076.96 | 670.77 Thousand | 919.92 Thousand | 571.16 Thousand | 759.24 Thousand | 434.45 Thousand |
| Net cash flow / Change in cash | -6.24 Million | -56.57 Million | -38.44 Million | 22.64 Million | -99.04 Million | -12.06 Million |
| Free Cash Flow | 141.34 Million | 48.25 Million | -20.36 Million | 23.94 Million | 58.67 Million | 51.17 Million |
WDGNF
5522
APP
NOHAL
MILFF
LAS